Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy

Weijun Wang, Nian Ling Zhu, Jason Chua, Steve Swenson, Fritz K. Costa, Stephanie Schmitmeier, Barbara A. Sosnowski, Toshiaki Shichinohe, Noriyuki Kasahara, Thomas C. Chen

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Object. Adenovirus vector (AdV)-mediated gene delivery has been recently demonstrated in clinical trials as a novel potential treatment for malignant gliomas. Combined coxsackievirus B and adenovirus receptor (CAR) has been shown to function as an attachment receptor for multiple adenovirus serotypes, whereas the vitronectin integrins (αvβ3 and αvβ5) are involved in AdV internalization. In resected glioma specimens, the authors demonstrated that malignant gliomas have varying levels of CAR, αvβ3, and αvβ5 expression. Methods. A correlation between CAR expression and the transduction efficiency of AdV carrying the green fluorescent protein in various human glioblastoma multiforme (GBM) cell lines and GBM primary cell lines was observed. To increase transgene activity in in vitro glioma cells with low or deficient levels of CAR, the authors used basic fibroblast growth factor (FGF2) as a targeting ligand to redirect adenoviral infection through its cognate receptor, FGF receptor 1 (FGFR1), which was expressed at high levels by all glioma cells. These findings were confirmed by in vivo study data demonstrating enhanced transduction efficiency of FGF2-retargeted AdV in CAR-negative intracranial gliomas compared with AdV alone, without evidence of increased angiogenesis. Conclusions. Altogether, the results demonstrated that AdV-mediated gene transfer using the FGF2/FGFR system is effective in gliomas with low or deficient levels of CAR and suggested that FGF2-retargeting of AdV may be a promising approach in glioma gene therapy.

Original languageEnglish (US)
Pages (from-to)1058-1066
Number of pages9
JournalJournal of neurosurgery
Issue number6
StatePublished - Dec 2005
Externally publishedYes


  • Adenoviral vector
  • Basic fibroblast growth factor
  • Gene transfer
  • Malignant glioma
  • Mouse

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy'. Together they form a unique fingerprint.

Cite this